These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 26678086)
1. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis. Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis. Zheng C; You W; Wan P; Jiang X; Chen J; Zheng Y; Li W; Tan J; Zhang S Medicine (Baltimore); 2018 Jun; 97(25):e11004. PubMed ID: 29923984 [TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma. Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931 [TBL] [Abstract][Full Text] [Related]
4. Bone versus soft-tissue sarcomas in the elderly. Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836 [TBL] [Abstract][Full Text] [Related]
5. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation. Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756 [TBL] [Abstract][Full Text] [Related]
6. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis. Wang N; He YL; Pang LJ; Zou H; Liu CX; Zhao J; Hu JM; Zhang WJ; Qi Y; Li F PLoS One; 2015; 10(3):e0121448. PubMed ID: 25822802 [TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095 [TBL] [Abstract][Full Text] [Related]
8. The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis. Wang F; Yu T; Ma C; Zhang H; Zhang Z FEBS Open Bio; 2019 Oct; 9(10):1744-1755. PubMed ID: 31376222 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors]. Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395 [No Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis. Wu J; Wu X; Liang W; Chen C; Zheng L; An H Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis. Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833 [TBL] [Abstract][Full Text] [Related]
12. [Molecular diagnosis of routine sarcomas]. Coindre JM Ann Pathol; 2008 Nov; 28 Spec No 1(1):S64-5. PubMed ID: 18984305 [No Abstract] [Full Text] [Related]
13. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942 [TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas. Paydas S; Bagir EK; Deveci MA; Gonlusen G Med Oncol; 2016 Aug; 33(8):93. PubMed ID: 27421997 [TBL] [Abstract][Full Text] [Related]
15. Sarcomas of Soft Tissue and Bone. Ferrari A; Dirksen U; Bielack S Prog Tumor Res; 2016; 43():128-41. PubMed ID: 27595362 [TBL] [Abstract][Full Text] [Related]
16. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients. Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435 [TBL] [Abstract][Full Text] [Related]
17. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis. Qiu L; Xu Y; Xu H; Yu B BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma. Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933 [TBL] [Abstract][Full Text] [Related]
19. Grb2-associated binding protein-1 as a biomarker in bone and soft tissue sarcomas. Al-Husseinawi E; Bui MM; Ahmed AA Pathology; 2019 Oct; 51(6):610-614. PubMed ID: 31443923 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study. Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]